Nordberg, Björn
Kaguiri, Eunice
Chamorro de Angeles, Katrine J.
Gabriel, Erin E.
van der Kop, Mia Liisa
Mwangi, Winfred
Lester, Richard T.
Were, Edwin
Ekström, Anna Mia
Rautiainen, Susanne
Funding for this research was provided by:
Stig and Ragna Gorthon's foundation (2021-2735)
Stiftelsen Läkare mot AIDS Forskningsfond (FOa2017-0006)
European and Developing Countries Clinical Trials Partnership (1104 EACCR2 EDCTP-RegNet2015)
Karolinska Institute
Article History
Received: 1 June 2023
Accepted: 12 December 2023
First Online: 3 January 2024
Declarations
:
: We obtained ethical approval from the Institutional Research and Ethics Committee at Moi University, Kenya (FAN: IREC 1292) and the Regional Ethics Committee, Stockholm, Sweden (2018/742–31/1). Written informed consent was provided by all participants before enrolment in the study. All trial procedures were performed in accordance with relevant guidelines and regulations.
: Not applicable.
: This study used a technology platform (WelTel/SMS) that was developed by a non-profit organisation and a private company. A co-investigator, RTL, has financial and professional interests in both organisations. RTL reports competing interests from his involvement in the WelTel International mHealth Society and WelTel Inc, grants from National Institutes of Health (NIH), Canadian Institutes of Health Research (CIHR), BC Lung Association, British Columbia Centre for Disease Control Foundation, and Grand Challenges Canada, and non-financial support from the WHO and Task Force on Digital Health for TB Control, outside the submitted work. The other authors declare that they have no competing interests.